C. Cannan

发表

Beyond the Coronary Angiogram: Further Evaluation of the Coronary Vasculature and Endothelial Function

S. Higano, D. Holmes, A. Lerman, 1996 .

Evaluation of patients with minimally obstructive coronary artery disease and angina.

D. Holmes, A. Lerman, D. Hasdai, 1996, International journal of cardiology.

Cardiac magnetic resonance imaging: current status and future directions

M. Friedrich, C. Cannan, 2010, Expert review of cardiovascular therapy.

Acute endothelin-receptor inhibition does not attenuate acetylcholine-induced coronary vasoconstriction in experimental hypercholesterolemia.

R. Schwartz, D. Holmes, A. Lerman, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.

A. Lerman, J. Burnett, C. Cannan, 1995, Circulation.

Prognosis with abnormal thallium images in the absence of significant coronary artery disease.

K. Bailey, R. Gibbons, T. Miller, 1992, The American journal of cardiology.

Coronary vascular remodeling in association with endothelial dysfunction.

D. Holmes, R. Nishimura, A. Lerman, 1998, The American journal of cardiology.

New insight into coronary endothelial dysfunction: role of endothelin.

A. Lerman, C. Cannan, V. Mathew, 1998, The Journal of laboratory and clinical medicine.

Enhanced Coronary Vasoconstriction to Endothelin-BReceptor Activation in Experimental Congestive Heart Failure

A. Lerman, J. Burnett, C. Cannan, 1996 .

Altered coronary endothelial function in a patient with asymptomatic left ventricular dysfunction.

D. Holmes, A. Lerman, C. Cannan, 1996, International journal of cardiology.

Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure.

A. Lerman, J. Burnett, C. Cannan, 1996, Circulation.

CMR features of peri-partum cardiomyopathy

M. Friedrich, S. Weeks, C. Cannan, 2010 .

Hemorrhage in the myocardium following infarction.

M. Friedrich, Andreas Kumar, I. Eitel, 2010, JACC. Cardiovascular imaging.

Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia.

R. Schwartz, D. Holmes, V. Miller, 1997, Circulation.

Hypertrophic cardiomyopathy: Who is at risk?

G. Reeder, C. Cannan, 1996 .

Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.

S. Kelsey, K. Detre, C. Cannan, 1999, The American journal of cardiology.

Antithrombotic therapy in cardiac stent patients

C. Cannan, 2001, Current cardiology reports.

Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

K. Bailey, L. Melton, B. Gersh, 1995, Circulation.

Novel perfusion sleeve for use during balloon angioplasty: initial clinical experience.

A. Kaplan, C. Cannan, D. Williams, 1998, Catheterization and cardiovascular diagnosis.

Echocardiographic assessment of commissural calcium: a simple predictor of outcome after percutaneous mitral balloon valvotomy.

D. Holmes, D. Larson, R. Nishimura, 1997, Journal of the American College of Cardiology.

Pacemaker Induced Mitral Regurgitation: An Alternative Form of Pacemaker Syndrome

S. Higano, D. Holmes, C. Cannan, 1997, Pacing and clinical electrophysiology : PACE.

Thoracic manifestations after esophageal variceal sclerotherapy.

U. Prakash, C. Cannan, F. Zeller, 1991, Mayo Clinic proceedings.

Subspecialty Clinics: Thoracic Diseases Thoracic Manifestations After Esophageal Variceal Sclerotherapy

U. Prakash, C. Cannan, F. Zeller, 1991 .

Echocardiographic identification of commissural calcium: A simple but effective predictor of outcome after percutaneous mitral balloon valvuloplasty

D. Holmes, C. Cannan, D. Ilstrup, 1996 .

The ten most commonly asked questions about intracoronary stents.

D. Holmes, C. Cannan, 2001, Cardiology in review.